29.01.2013 • NewsLanxessPaul SchlackPerlon

75 Years of Perlon

© Fotolia / skampixel
© Fotolia / skampixel

In 1938, chemist Paul Schlack discovered the basic principles needed to develop a robust synthetic fiber that has become world famous under the name Perlon. The fiber first made its name through its use in stockings in the 1950s. Today the synthetic material has a very diverse range of applications.

It no longer adorns women's legs but is instead used as a strong plastic filament in fishing lines, field fencing, lines for oyster baskets, and tough hawsers for ships. All over the world, such hawsers of up to 95 millimeters in thickness have been securing boats, yachts and ships to dry land for almost 50 years. Perlon as well as the Bayco and Atlas brands are manufactured by Perlon-Monofil, a 100% subsidiary of Lanxess. Each year, the company produces around 27,000 kilometers of monofilament for use in the shipping industry.

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.